Table 2.
Parameter | Importance score | Spearman’s (r) | p-value |
---|---|---|---|
Hypercholesterolemia | 15.96 | 0.38 | < 0.0001 |
Plaque score L | 12.68 | 0.41 | < 0.0001 |
Plaque score R | 10.94 | 0.38 | < 0.0001 |
Duration of T2DM | 10.65 | 0.32 | < 0.0001 |
Plaque area R | 10.00 | 0.34 | < 0.0001 |
Age | 8.60 | 0.37 | < 0.0001 |
Plaque area L | 8.36 | 0.35 | < 0.0001 |
Betabloker | 7.66 | 0.25 | 0.0004 |
T2DM | 7.08 | 0.24 | 0.0008 |
Hypertension | 6.83 | 0.24 | 0.0010 |
cfPWV | 6.64 | 0.28 | < 0.0001 |
ALT | 4.69 | –0.15 | 0.0329 |
eGFR | 3.51 | –0.28 | < 0.0001 |
HbA1c | 3.19 | 0.22 | 0.0025 |
Obesity | 3.17 | –0.15 | 0.0421 |
We report the two-tailed p-values for nonparametric Spearman correlation to verify if the correlation is due to random sampling (if p < 0.05 this hypothesis can be rejected)
T2DM type 2 diabetes mellitus, cfPWV carotid-femoral pulse wave velocity, ALT alanine aminotransferase, eGFR estimated glomerular filtration rate, HbA1c hemoglobin A1c